Steve Deacon

Steve Deacon currently serves as Chief Scientific Officer at Pharmanovia since May 2022. Previously, Steve held the position of Chief Executive Officer and Chief Development Officer at Haoma Medica Ltd. from July 2019 to June 2022, and worked as a Drug Development Consultant on a freelance basis from December 2018 to June 2019. From August 2007 to November 2018, Steve was Senior Vice President and Head of EU/US Drug Development at ONO PHARMA, and prior roles included Vice President of Clinical Development (Europe) and Senior Director of Clinical Development. Earlier experience includes positions at LUNDBECK UK LLP, SmithKline Beecham, and a lecturer role in physiology and chemistry at the University of Surrey. Steve's academic background includes a PhD in Human Circadian Physiology & Behaviour from the University of Surrey and a Bachelor's degree in Applied Biological Sciences from the University of the West of England. Research interests focus on human circadian physiology and clinical research involving melatonin.